FOLD — AMICUS THERAPEUTICS INC

Ownership history in nVerses Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.16% (2024 Q1)
Avg. % of fund
0.1%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 17,500 — 0% 0.09% $187K $7.88
2025 Q2 UNCHANGED 17,500 — 0% 0.09% $187K $5.73
2025 Q1 UNCHANGED 17,500 — 0% 0.09% $187K $8.16
2024 Q4 UNCHANGED 17,500 — 0% 0.09% $187K $9.42
2024 Q3 ADDED 17,500 +11,900 +212.5% 0.09% $187K $10.68
2024 Q1 INITIATED 5,600 — — 0.16% $66K —
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Athos Capital Ltd 3Y 7Y 3.27% Chicago Capital Management, LLC 3Y 7Y 2.92% Bellevue Group AG 3Y 7Y 2.9% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75%
← Back to nVerses Capital, LLC Holdings